17.80
-0.74
(-3.99%)
At close: January 10 at 4:00:01 PM EST
17.80
0.00
(0.00%)
After hours: January 10 at 4:00:12 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-108,985.41
-93,049.09
-67,162.63
-44,599.68
-21,499.59
Investing Cash Flow
-405.55
-89.98
-124.30
-130.03
-42.98
Financing Cash Flow
263,841.50
325,393.00
8,650.37
143,671.34
101,200.80
End Cash Position
312,809.27
391,231.64
161,837.43
209,353.13
98,628.87
Capital Expenditure
-405.55
-89.98
-124.30
-130.03
-42.98
Issuance of Capital Stock
280,361.78
342,911.32
9,609.87
156,825.70
102,514.88
Repayment of Debt
-187.73
-220.51
-119.53
--
--
Free Cash Flow
-109,390.96
-93,139.08
-67,286.93
-44,729.72
-21,542.57
12/31/2020 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TRML Tourmaline Bio, Inc.
19.70
-1.50%
AVBP ArriVent BioPharma, Inc.
24.88
-7.37%
MOLN Molecular Partners AG
4.9837
-5.97%
64Z.F Keymed Biosciences Inc.
3.3400
-2.91%
GEM.F GeNeuro SA
0.1400
+7.69%
ZBIO Zenas BioPharma, Inc.
8.12
-12.50%
INCPF InnoCare Pharma Limited
3.2600
0.00%
ALVR AlloVir, Inc.
0.4391
-2.38%
BIOA-B.ST BioArctic AB (publ)
206.80
+1.08%
CRGX CARGO Therapeutics, Inc.
13.50
-4.93%